Chinese (Regulatory) Checkers

  • by: |
  • 09/04/2012

The problem is that, after this important joint action, we're still hungry for more.

The China State Food and Drug Administration (SFDA) has joined forces with the FDA to shut down 18 Chinese-language web sites selling illegal drugs.

According to China Daily's report on Tuesday, the Sino-U.S. collaboration was launched in June this year and targeted Web sites in the U.S. advertising counterfeit drugs and health food. The 18 sites take down were run and hosted by Chinese speakers and aimed for Chinese consumers including Chinese Americans around the world, said Christopher Hickey, director of the U.S. FDA's China office.

"We welcome and appreciate the role played by the China State Food and Drug Administration to initiate the campaign and hope to continue combined efforts in the global fight against counterfeit drugs," he added.

The Sino-US collaborations was also part of a national clampdown on fake and illegal drugs within mainland China, said SFDA spokesperson Wang Lianglan in the report.

The operation saw police seizing 205 million tablets designed to look like branded drugs for treating male impotence, hypertension, diabetes and cancer, it noted. Wang added the SFDA will step up operations in the rest of the year with other law enforcement agencies and government departments to curb counterfeit medicince.

The next phase will see them enhance inspection of clinical trial for drugs made in China and meant for export to the United States, Hickey said.

CMPI

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
AHRP
Better Health
BigGovHealth
Biotech Blog
BrandweekNRX
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
CNEhealth.org
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
eDrugSearch
Envisioning 2.0
EyeOnFDA
FDA Law Blog
Fierce Pharma
fightingdiseases.org
Fresh Air Fund
Furious Seasons
Gooznews
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
IgniteBlog
In the Pipeline
In Vivo
Instapundit
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
KevinMD
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
Medrants
More than Medicine
National Review
Neuroethics & Law
Newsbusters
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
PAL
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmablogger
Pharmacology Corner
Pharmagossip
Pharmamotion
Pharmalot
Pharmaceutical Business Review
Piper Report
Polipundit
Powerline
Prescription for a Cure
Public Plan Facts
Quackwatch
Real Clear Politics
Remedyhealthcare
Shark Report
Shearlings Got Plowed
StateHouseCall.org
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
TortsProf
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog